ArticleBMC infectious diseases2021

Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.

Xiuting Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.